Your leading voice in digital health news
Twitter X Logo

 
close
Home
/
News
/
ResApp Health

ResApp Health

27 September 2022

Pfizer completes $179m purchase of ResApp Health

Global pharmaceutical giant Pfizer has finalised its $179 million takeover of Brisbane-based, ASX-listed respiratory technology company ResApp Health. Pfizer announced…
Continue Reading
19 April 2022

Pfizer makes $100 million bid for ResApp Health

Pharmaceutical giant Pfizer has made an offer worth approximately $100 million to buy 100 per cent of the shares in…
Continue Reading
22 March 2022

ResApp to develop COVID-19 mass screening tool as adjunct to RATs and PCR

ASX-listed respiratory app technology developer ResApp is in the early stages of planning a randomised control trial of its new…
Continue Reading
2 March 2022

Health Teams to launch ResAppDx on aged care telehealth platform

Aged care patient monitoring platform provider Health Teams has signed an agreement with respiratory disease app vendor ResApp Health to…
Continue Reading
31 January 2022

ResAppDx live with Doctors on Demand telehealth platform

ResApp Health’s smartphone-based acute respiratory diagnostic test ResAppDx has now been implemented in Doctors on Demand’s online telehealth platform. Doctors…
Continue Reading
29 March 2021

TGA approval for ResApp’s wearable device for cough monitoring

ASX-listed digital health company ResApp Health has received TGA approval to list its new wearable device for monitoring cough on…
Continue Reading
26 October 2020

ResApp partners with HealthEngine for SleepCheck integration

ASX-listed respiratory app developer ResApp Health has signed an agreement with HealthEngine to integrate its appointment booking engine with ResApp’s…
Continue Reading
12 October 2020

ResApp partners with Diabetes Queensland to promote SleepCheck app

ASX-listed ResApp Health has partnered with Diabetes Queensland to promote its mobile medical application SleepCheck and raise awareness of sleep…
Continue Reading
1 July 2020

ResApp releases SleepCheck app for at-home sleep apnoea screening

ASX-listed ResApp has released its SleepCheck at-home sleep apnoea screening app for iPhones. The app is able to analyse a…
Continue Reading
22 June 2020
 | 1 Comment

ResApp to develop consumer respiratory app, to go live with Phenix app

ASX listed digital health company ResApp has signed a memorandum of understanding with health products manufacturer RB, formerly known as…
Continue Reading
1 2
Load More

Sign Up to your leading voice in digital health news 

Join 20,000+ professionals reading the latest in digital health news.

Log in to Pulse+IT

Not a member yet?
Subscribe here
Forgot your password?

Explore by category

Aged, community and disability care Allied Health Asia Pacific Health IT Australian Digital Health Digital Health Opinion EU Movers and Shakers Irish Digital Health Movers and shakers New Zealand Digital Health Opinion Pulse+IT Blog Uncategorised 

Your leading voice in digital health news

Twitter X

Copyright © 2024 Pulse IT Communications Pty Ltd. No content published on this website can be reproduced by any person for any reason without the prior written permission of the publisher. If your organisation is featured in a Pulse+IT article you can purchase the permission to reproduce the article here.
Website Design by Get Leads AU.

Privacy Policy

Your leading voice in digital health news 

Keep your finger on the pulse with full access to all articles published on 
pulseit.news
Subscribe from only $39
magnifiercrossmenuchevron-downarrow-right